David A. Karanian, Ph.D.
Affiliations: | University of Connecticut, Storrs, CT, United States |
Area:
Neuroprotection in models of Alzheimer-type pathogenesisGoogle:
"David Karanian"Mean distance: 30533.1
Parents
Sign in to add mentor| Ben A. Bahr | grad student | 2005 | University of Connecticut | |
| (The endocannabinoid system: Cellular and functional protection against stroke-type brain damage.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Farizatto KLG, McEwan SA, Naidoo V, et al. (2017) Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo Neurotoxic Effects of Paraoxon. Journal of Molecular Neuroscience : Mn |
| Naidoo V, Karanian DA, Vadivel SK, et al. (2012) Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 9: 801-13 |
| Naidoo V, Nikas SP, Karanian DA, et al. (2011) A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity. Journal of Molecular Neuroscience : Mn. 43: 493-502 |
| Williams J, Wood J, Pandarinathan L, et al. (2007) Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Analytical Chemistry. 79: 5582-93 |
| Karanian DA, Karim SL, Wood JT, et al. (2007) Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage. The Journal of Pharmacology and Experimental Therapeutics. 322: 1059-66 |
| Kosten TA, Karanian DA, Yeh J, et al. (2007) Memory impairments and hippocampal modifications in adult rats with neonatal isolation stress experience. Neurobiology of Learning and Memory. 88: 167-76 |
| Butler D, Bendiske J, Michaelis ML, et al. (2007) Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers. European Journal of Pharmacology. 562: 20-7 |
| Karanian DA, Bahr BA. (2006) Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states. Current Molecular Medicine. 6: 677-84 |
| Karanian DA, Baude AS, Brown QB, et al. (2006) 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism. Hippocampus. 16: 834-42 |
| Bahr BA, Karanian DA, Makanji SS, et al. (2006) Targeting the endocannabinoid system in treating brain disorders. Expert Opinion On Investigational Drugs. 15: 351-65 |